The Gut Microbiome, Seleno-Compounds, and Acute Myocardial Infarction

Fu-Chun Chiu,Chin-Feng Tsai,Pang-Shuo Huang,Ching-Yu Shih,Mong-Hsun Tsai,Juey-Jen Hwang,Yi-Chih Wang,Eric Y. Chuang,Chia-Ti Tsai,Sheng-Nan Chang
DOI: https://doi.org/10.3390/jcm11051462
IF: 3.9
2022-03-07
Journal of Clinical Medicine
Abstract:Background: Gut microbiome alterations might be considered a metabolic disorder. However, the relationship between the microbiome and acute myocardial infarction (AMI) has not been properly validated. Methods: The feces of 44 subjects (AMI: 19; control: 25) were collected for fecal genomic DNA extraction. The variable region V3–V4 of the 16S rRNA gene was sequenced using the Illumina MiSeq platform. The metabolite amounts were analyzed using the Kyoto Encyclopedia of Genes and Genomes (KEGG) metabolic pathways. Results: The bacteria were more enriched in the AMI group both in the observed operational taxonomic units (OTUs) and faith phylogenetic diversity (PD) (p-value = 0.01 and 2). Seleno-compounds were more abundant in the AMI group at the family, genus, and species levels (all LDA scores > 2). Conclusions: This is the first study to demonstrate the association of Selenomonadales and seleno-compounds with the occurrence of AMI. Our findings provide an opportunity to identify a novel approach to prevent and treat AMI.
medicine, general & internal
What problem does this paper attempt to address?